Tatva Chintan Pharma Chem Ltd consolidated Q1 FY23 PAT falls to Rs. 9.79 crores

Tatva Chintan Pharma Chem Ltd has reported Consolidated financial results for the period ended June 30, 2022.

Financial Results (Q1 FY2023) - QoQ Comparison

The company has reported total income of Rs. 90.231 crores during the period ended June 30, 2022 as compared to Rs. 98.885 crores during the period ended March 31, 2022.

The company has posted net profit / (loss) of Rs. 9.797 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs. 17.509 crores for the period ended March 31, 2022.

The company has reported EPS of Rs. 4.42 for the period ended June 30, 2022 as compared to Rs. 7.90 for the period ended March 31, 2022.

Financials	Q1 FY2023	Q4 FY2022	% Change
Total Income	₹ 90.231 crs	₹98.885 crs	-8.75%
Net Profit	₹9.797 crs	₹17.509 crs	-44.05%
EPS	₹4.42	₹7.90	-44.05%

Financial Results (Q1 FY2023) - YoY Comparison

The company has reported total income of Rs. 90.231 crores during the period ended June 30, 2022 as compared to Rs.108.154 crores during the period ended June 30, 2021.

The company has posted net profit / (loss) of Rs.9.797 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs.23.146 crores for the period ended June 30, 2021.

The company has reported EPS of Rs.4.42 for the period ended June 30, 2022 as compared to Rs.11.52 for the period ended June 30, 2021.

Financials	Q1 FY2023	Q1 FY2022	% Change
Total Income	₹ 90.231 crs	₹108.154 crs	-16.57%
Net Profit	₹9.797 crs	₹23.146 crs	-57.67%
EPS	₹4.42	₹11.52	-61.63%

Shares of Tatva Chintan Pharma Chem Ltd was last trading in BSE at Rs. 2365.90 as compared to the previous close of Rs. 2361.35. The total number of shares traded during the day was 239 in over 149 trades.

The stock hit an intraday high of Rs. 2385.55 and intraday low of 2355.00. The net turnover during the day was Rs. 567335.00.

Source : Equity Bulls

Keywords

TatvaChintanPharmaChem Q1FY23 ResultUpdate